Development and validation of a multiparameter prognostic model for extranodal natural killer/T-cell lymphoma: Integration of clinical, pathological, and molecular biomarkers
Cytojournal · 09.04.2026 · 23 · 24
DOI: 10.25259/cytojournal_34_2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cytojournal, online erschienen am 09.04.2026. Verfasst von Shishou Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Yantai Yuhuangding Hospital, Yantai, China. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objectives
The objectives of the study are to develop and validate a novel prognostic model for extranodal natural killer/T-cell lymphoma (ENKTCL) by integrating clinical and pathological parameters. Material and Methods: We retrospectively analyzed 106 patients with ENKTCL (2008–2020) from the Department of Pathology of Yantai Yuhuangding Hospital and the Affiliated Hospital of Nantong University, constructing the novel international prognostic index (NIPI) model through multivariable Cox regression of immunohistochemistry (IHC) markers (age, MTP53, Ki-67, lactate dehydrogenase, hemoglobin, platelet-tolymphocyte ratio) and quantitative dot blot (QDB) tumor microenvironment features.
Results
The model demonstrated significant risk stratification ( P < 0.001) with a 3-year area under the curve of 0.72 (IHC) and 0.80 (QDB), outperforming Ann Arbor staging ( P > 0.05) and existing international prognostic index ( P = 0.00036)/natural killer lymphoma prognostic index ( P = 0.00017) models. The QDB-based implementation showed superior prognostic discrimination ( P = 0.00014), highlighting its potential for precise individualized therapy.
Conclusion
NIPI provides improved risk stratification for ENKTCL, and QDB-based analysis offers enhanced precision in individualized therapy. This model addresses the unmet needs for ENKTCL prognostication and warrants further multicenter validation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Yantai Yuhuangding Hospital, Yantai, China.
- Department of Pathology, Affiliated Hospital of Nantong University, Nantong, China.
- Department of Hematology, Yantai Yuhuangding Hospital, Yantai, China.
ORCID-Profile: Liling Song
Zitieren
APA
Wu, S., Liu, Y., Jiang, L., An, L., Zhang, Y., Pan, Y., Song, L., Wang, Y., & Yu, G. (2026). Development and validation of a multiparameter prognostic model for extranodal natural killer/T-cell lymphoma: Integration of clinical, pathological, and molecular biomarkers. Cytojournal, 23, 24. https://doi.org/10.25259/cytojournal_34_2025
Vancouver
Wu S, Liu Y, Jiang L, An L, Zhang Y, Pan Y, et al. Development and validation of a multiparameter prognostic model for extranodal natural killer/T-cell lymphoma: Integration of clinical, pathological, and molecular biomarkers. Cytojournal. 2026;23:24. doi:10.25259/cytojournal_34_2025
BibTeX
@article{Wu2026,
author = {Wu, Shishou and Liu, Yifei and Jiang, Lei and An, Licai and Zhang, Yuanfeng and Pan, Yu and Song, Liling and Wang, Yunjun and Yu, Guohua},
title = {Development and validation of a multiparameter prognostic model for extranodal natural killer/T-cell lymphoma: Integration of clinical, pathological, and molecular biomarkers},
journal = {Cytojournal},
year = {2026},
volume = {23},
pages = {24},
doi = {10.25259/cytojournal_34_2025}
}
EUVIMED